** = Publikationen gelistet in SCI/SSCI/Pubmed
** Klocker, EV; Dobric, N; Graf, R; Beichler, C; Hlauschek, D; Suppan, C; Pancheri, L; Egle, D; Albertini, C; Bartsch, R; Starzer, AM; Jost, PJ; Rinnerthaler, G; Heitzer, E; Dandachi, N; Balic, M
Clinical impact of single-gene vs. panel sequencing in advanced HR
NPJ BREAST CANCER. 2025; 11(1): 86
Doi: 10.1038/s41523-025-00805-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dandachi, N; Graf, R; Pancheri, L; Dobric, N; Klocker, EV; Suppan, C; Jost, PJ; Heitzer, E; Balic, M
A head-to-head comparison for detecting PIK3CA mutations in circulating tumor DNA of advanced HR+/HER2-breast cancer patients
ANN ONCOL. 2023; 34: S1162-S1163.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Madrid, SPAIN.
Doi: 10.1016/j.annonc.2023.09.1289
[Poster]
Web of Science
FullText
FullText_MUG
** Dobric, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M
Comparison of ctDNA profiles from HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients
ANN ONCOL. 2023; 34: S387-S387.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Madrid, SPAIN.
Doi: 10.1016/j.annonc.2023.09.667
[Poster]
Web of Science
FullText
FullText_MUG